We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

77 ELEKTRONIKA

Develops, manufactures, and markets fully automated and semi-automated urine analyzers, rapid test readers and their ... read more Featured Products: More products

Download Mobile App





77 Elektronika Highlights Latest Urinanalysis Solutions at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023

77 Elektronika (Budapest, Hungary) is participating at Medlab Middle East 2023 where the company is showcasing its full product range, including its latest urine test strip - the LabStrip U12 mALB/CREA - alongside the new DocUReader 2 Pro urine analyzer. More...

At Medlab Middle East 2023, 77 Elektronika is demonstrating the LabStrip U mALB/CREA urine test strips designed for the semi-quantitative determination of albumin and creatinine in fresh human urine and the screening of samples for microalbuminuria. LabStrip U mALB/CREA is intended to be used as a screening test for the detection of pathologies associated with kidney diseases. Each test strip contains two test zones, which incorporate sensitive chemicals. If these zones come into contact with urine, a chemical reaction takes place, which results in the discoloration of the test zone.

The urine test strips can be evaluated and read on the new DocUReader 2 Pro urine analyzer that is also on display at the show. The instrument is intended for in vitro diagnostic use by qualified physicians and laboratory staff, but does not require special training to be used. The compact design of this lightweight instrument offers the broadest features and highest flexibility available on any desktop size urine analyzer. The system offers excellent accuracy, simple operation, high flexibility and connectivity as well as enhanced security and quality control functions.

In addition, 77 Elektronika is showcasing the LabUMat 2 and Urised 3 Pro that combines chemistry and sediment analysis in one system. The LabUMat 2 is a high throughput, automated urine chemistry analyzer that can evaluate 10 chemical parameters of LabStrip U11 Plus GL test strips and three physical parameters of urine samples. The UriSed 3 is an automated urine sediment analyzer providing whole field of view microscopic images of urine sediment and detecting 16 sediment particles using Urised Cuvettes. The efficiencies of the LabUMat 2 and the UriSed 3 are maximized when these instruments are used as one system.

Related Links:
77 Elektronika 


New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Automatic CLIA Analyzer
Shine i6000
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.